This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various therapeutic agents, especially those targeting the central nervous system (CNS). Its structural features make it valuable for designing molecules with potential applications in treating neurological disorders, such as depression, anxiety, and cognitive impairments. Additionally, it is explored in the development of drugs with improved bioavailability and selectivity due to its fluorinated pyrrolidine moiety, which can enhance binding affinity and metabolic stability. Researchers also investigate its role in creating novel compounds for addressing unmet medical needs in areas like pain management and neurodegenerative diseases.